COVID-19 public health information from the US CDC |
COVID-19 research information from the US NIH |
COVID-19 resources for global health researchers
Italy and US reach drug abuse research accord
September / October 2011 | Volume 10, Issue 5
Photo courtesy of NIDA
NIDA Director Dr. Nora Volkow (left) signed a research
collaboration agreement with Italy’s Department of
In the interest of furthering global health and fighting addiction, the National Institute on Drug Abuse (NIDA) and Italy’s Department of Anti-Drug Policies have signed a formal agreement that will promote scientific collaboration between the two countries. The agreement identifies several research areas of focus to help prevent and treat drug abuse and addiction. These include: screening for early detection, brief intervention and improved treatment for addictive disorders, especially among adolescents and young adults.
"This agreement serves as a model for how scientific collaboration can help reduce the burden of substance abuse and addiction around the world," said NIDA Director Dr. Nora Volkow, "benefiting the larger scientific community and the millions of people who suffer from these often devastating disorders."
Representing the Italian government were Senator Carlo Giovanardi, Italian Undersecretary of State for Family, Drugs and Civil Service and Giovanni Serpelloni, head of the Italian Department of Anti-Drug Policies.
This agreement follows the Memorandum of Intent, signed a few weeks earlier, between the White House’s Office of National Drug Control Policy and the Italian Government. Together, these agreements represent an international effort to promote drug policy collaboration and scientific exchange.
To view Adobe PDF files,
download current, free accessible plug-ins from Adobe's website.
Related World Regions / Countries